Concepció Jacobs Cachá Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Email Concepció Jacobs Cachá Email Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca
Projects The interplay between ACE2 and AXL systems to predict COVID-19 disease severity and outcomes IP: Maria Jose Soler Romeo Collaborators: Concepció Jacobs Cachá Funding agency: Fundació La Marató de TV3 Funding: 154125 Reference: 202133-30 Duration: 23/09/2021 - 22/09/2024 Caracterización molecular de Apolipoproteína A-Ib (ApoA-Ib): resolviendo el enigma del síndrome nefrótico idiopático. IP: Concepció Jacobs Cachá Collaborators: - Funding agency: Fundación Renal Iñigo Alvarez de Toledo Funding: 6000 Reference: FRIAT/PREMIS/2020/JACOBS Duration: 22/09/2020 - 22/09/2020 Deciphering the Mechanisms of PLA2R-specific B-cell Autoimmunity in Primary Membranous Nephropathy (PMN)(BCELL-MEM) IP: Maria Jose Soler Romeo Collaborators: Laura Donadeu Casassas, Oriol Bestard Matamoros, Elena Isabel Crespo Gimeno, Concepció Jacobs Cachá Funding agency: Fundació La Marató de TV3 Funding: 199935.54 Reference: 202037-31 Duration: 01/06/2021 - 31/12/2024 Role of Apolipoprotein A-Ib in the idiopathic nephrotic syndrome IP: Concepció Jacobs Cachá Collaborators: - Funding agency: Fundació La Marató de TV3 Funding: 199966.31 Reference: 202017/10 Duration: 30/03/2021 - 31/12/2024 Pagination First page « Previous page ‹ Page 1 Page 2 Current page 3 Page 4 Page 5 Next page › Last page »
